News

Deal Announcements

Aviir Adds Venture Capital Debt And Equity

Monday, December 5, 2011 5:36:00 AM PDT | VentureDeal Staff
Palo Alto, California  --  Biotechnology company Aviir has secured $750,000 in venture capital and debt, according to an SEC regulatory filing.

Aviir is commercializing diagnostic tests that it says enables more accurate diagnosis and prognosis of cardiovascular disease.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Aviir is still seeking an additional $750,000 in financing according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1